| Literature DB >> 26883368 |
Giuseppe Di Gioia1,2, Mariano Pellicano1,2, Gabor G Toth1,3, Filip Casselman1, Julien Adjedj1, Frank Van Praet1, Bernard Stockman1, Ivan Degrieck1, Bruno Trimarco2, William Wijns1, Bernard De Bruyne1, Emanuele Barbato4,5.
Abstract
We evaluated the clinical outcome of patients with moderate/severe aortic stenosis and significant coronary disease not treated according to guidelines, recommending combined aortic valve replacement (AVR) and coronary artery bypass grafting (CABG). From 2002 to 2010, we assessed death up to 5 years in 650 patients with moderate/severe aortic stenosis and at least one coronary lesion (>50 %): 23 % were treated conservatively (MT), 17 % with percutaneous coronary intervention (PCI), 11 % with AVR, and 49 % with combined CABG and AVR. At a median follow-up of 58 months, overall death decreased over the groups (MT, 68 % vs. PCI, 44 % vs. AVR, 34 % vs. CABG and AVR, 23 %, p < 0.01). Compared to the MT group, Cox regression analysis adjusted for potential confounders showed significantly reduced mortality in the PCI, AVR, and CABG and AVR groups. When combined CABG and AVR is not feasible, PCI or AVR alone still improves significantly long-term survival as compared with MT alone.Entities:
Keywords: Aortic valve disease; Coronary artery disease; Coronary bypass grafts; Percutaneous coronary intervention
Mesh:
Substances:
Year: 2016 PMID: 26883368 DOI: 10.1007/s12265-016-9680-6
Source DB: PubMed Journal: J Cardiovasc Transl Res ISSN: 1937-5387 Impact factor: 4.132